[
    [
        {
            "time": "",
            "original_text": "【浙商医药|周报】推荐Q3业绩高增长板块（API、CXO、检测），关注新冠疫苗Q4进展",
            "features": {
                "keywords": [
                    "浙商医药",
                    "周报",
                    "Q3业绩高增长",
                    "API",
                    "CXO",
                    "检测",
                    "新冠疫苗",
                    "Q4进展"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "API",
                    "CXO",
                    "检测"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医药|周报】推荐Q3业绩高增长板块（API、CXO、检测），关注新冠疫苗Q4进展",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]